A study reveals wide geographic disparities in type 1 diabetes incidence and prevalence, as well as pediatric endocrinologist availability, across the US.

Excess adiposity increases risk for vertebral fracture progression in postmenopausal women with early breast cancer receiving treatment with aromatase inhibitors ...

FDA approves updated 2026-2027 COVID-19 vaccine formulations from Pfizer/BioNTech, Moderna, and Novavax targeting the XFG variant for vulnerable populations.

Semaglutide use before or during pregnancy may increase risk for adverse outcomes like gestational diabetes and excessive weight gain.

The artificial sweetener xylitol is independently associated with the incident risk for MACE in the general population.

There was a 10-fold increase in youth-onset type 2 diabetes from 2002 to 2023, according to a study to be presented at the annual meeting of the European Associ ...

For patients with obesity and primary aldosteronism, there is a link to a higher cardiometabolic burden and poorer clinical response to targeted treatments.

The FDA added a boxed warning to Injectafer (ferric carboxymaltose) regarding symptomatic hypophosphatemia and the need for phosphate monitoring.

Black and Hispanic vs non-Hispanic White individuals with diabetes were less likely to use continuous glucose monitoring and insulin pumps.

Federal health officials have launched a web page that gathers the nation's drug overdose numbers, prevention tips, and treatment resources.

Lower adherence to blood pressure-lowering medication is associated with no benefit for preventing cardiovascular events.

Researchers found that childhood body mass index trajectories influence the likelihood of childbirth and infertility in adult women.